RELATED CONTENT
NEWS
- Advinus' glucokinase activator shows promise in clinical proof of concept study
- Amgen resolves patent suit, squashing Teva's neutropenia biosimilar until 2013
- $700m buys Amgen a Turkish footprint but how does MN fit its strategy?
- Amgen Q1: international sales and price rises to fill in for falls in Epogen, Aranesp
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

